Intra-Cellular Therapies

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
Clinical Trials Arena
Tue, 06/18/24 - 07:52 pm
Intra-Cellular Therapies
clinical trials
major depressive disorder
Caplyta
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
BioSpace
Thu, 04/18/24 - 10:23 pm
Intra-Cellular Therapies
funding
NASDAQ
Intra-Cellular Launches 26% To Record High, Breaking Out After Depression Drug Scores Big
Investors Business Daily
Tue, 04/16/24 - 11:13 am
Intra-Cellular Therapies
Caplyta
clinical trials
major depressive disorder
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Clinical Trials Arena
Wed, 03/29/23 - 09:40 am
Intra-Cellular Therapies
clinical trials
Caplyta
major depressive disorder
bipolar disorder
Why Intra-Cellular Therapies Took a Big Hit Today
Motley Fool
Tue, 01/4/22 - 10:52 pm
Intra-Cellular Therapies
Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner
Motley Fool
Mon, 12/20/21 - 10:57 am
biotech stocks
NASDAQ
vaccines
Novavax
Moderna Therapeutics
Ocugen
Intra-Cellular Therapies
Caplyta
5 FDA approval decisions to watch in the fourth quarter
BioPharma Dive
Sun, 10/3/21 - 08:32 pm
FDA
vaccines
COVID-19
Pfizer
BioNTech
JNJ
cilta cel
Biomarin
vosoritide
Intra-Cellular Therapies
lumateperone
Moderna Therapeutics
Intra-Cellular Bipolar Drug Shows "Significant" Benefit in Depressive Episodes
BioSpace
Tue, 09/28/21 - 11:10 am
Intra-Cellular Therapies
clinical trials
lumateperone
bipolar disorder
Fortunes diverge for solo drug launchers
EP Vantage
Tue, 05/11/21 - 11:01 am
drug launches
Intra-Cellular Therapies
Biocryst
Horizon Therapeutics
Karyopharm Therapeutics
Blueprint Medicines
Zogenix
Esperion
Epizyme
Aurinia Pharmaceuticals
Global Blood Therapeutics
Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics
BioSpace
Sat, 09/12/20 - 10:15 pm
biotech
IPOs
Intra-Cellular Therapies
10x Genomics
Spero Therapeutics
Important catalysts approach for smaller biotechs
EP Vantage
Wed, 06/24/20 - 10:35 am
BeiGene
Turning Point Therapeutics
Intra-Cellular Therapies
Immunovant
Caplyta
Brukinsa
repotrectinib
IMVT-1401
clinical trials
Intra-Cellular approval keeps focus on FDA's neuroscience review process
BioPharma Dive
Thu, 12/26/19 - 01:05 pm
FDA
Intra-Cellular Therapies
lumateperone
schizophrenia
Caplyta
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Mon, 12/16/19 - 10:52 am
Axsome Therapeutics
AXS-05
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
major depressive disorder
Intra-Cellular Therapies
lumateperone
schizophrenia
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
FDA
Amgen
Vascepa
Allergan
migraines
ubrogepant
Intra-Cellular Therapies
lumateperone
schizophrenia
4 FDA Dates Biotech Investors Should Circle in December
Motley Fool
Sun, 12/8/19 - 10:24 pm
FDA
Amgen
anti-inflammatories
ABP710
Bausch Health Companies
acne
IDP-123
Intra-Cellular Therapies
lumateperone
schizophrenia
Vascepa
Amarin
FDA cancels panel review of Intra-Cellular’s schizophrenia drug, causing shares to tumble
Stat
Tue, 07/23/19 - 07:41 pm
Intra-Cellular Therapies
FDA
advisory panels
schizophrenia
lumateperone
Intra-Cellular optimistic on lumateperone's future in bipolar despite mixed Phase III results
BioCentury
Mon, 07/8/19 - 08:16 pm
Intra-Cellular Therapies
lumateperone
clinical trials
bipolar disorder
FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb
Xconomy
Wed, 08/23/17 - 11:19 am
FDA
Intra-Cellular Therapies
lumateperone
schizophrenia

Pages